Luca Valenti

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu et al. · Hepatology · 2023 · 2.9K citations · Full text

Medicine, Internal Medicine, Pathology +17

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong et al. · Journal of Hepatology · 2024 · 1.6K citations · Full text

Medicine, Internal Medicine, Hepatology +9

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes

Anna Ludovica Fracanzani, Luca Valenti, Elisabetta Bugianesi et al. · Hepatology · 2008 · 702 citations

Medicine, Internal Medicine, Pathology +17

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent

Rosellina Margherita Mancina, Paola Dongiovanni, Salvatore Petta et al. · Gastroenterology · 2016 · 664 citations · Full text

Medicine, Internal Medicine, Epidemiology +9

Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease†

Luca Valenti, Ahmad Al‐Serri, Ann K. Daly et al. · Hepatology · 2010 · 649 citations · Full text

Medicine, Genetics, Molecular Genetics +13